VBrain
Vysioneer Inc. • Radiology • 12/16/2021
Device Purpose
VBrain is an AI-powered software intended to aid in radiation therapy treatment planning by using deep learning neural networks to automatically generate initial contours of diagnosed brain tumors and organs at risk on T1 contrast-enhanced MRI images. The system also features rigid image registration to enhance workflow, emphasizing that its outputs are for informational support and require expert clinical validation.
Summary
VBrain is a software device designed to assist trained medical professionals in the clinical workflow of radiation therapy treatment planning for adult patients with known (diagnosed) brain tumors. Its purpose is to provide initial object contours of specific brain tumors—metastases, meningiomas, and acoustic neuromas—and critical organs at risk (brain stem, eyes, optic nerves, optic chiasm) on axial T1 contrast-enhanced brain MRI images. VBrain employs an artificial intelligence algorithm, specifically deep learning neural networks, for this automated contouring (segmentation) task. Additionally, the software incorporates an automatic image registration feature to perform rigid registration of volumetric medical image data, such as MR and CT scans, adjusting their spatial position and orientation. The system is composed of a workflow management module and three algorithm modules: tumor contouring, OAR contouring, and image registration, which can function independently or be integrated. Both contouring modules utilize image preprocessing, deep learning neural networks, and postprocessing steps to generate contours as DICOM-RT objects. VBrain is intended for informational purposes, supporting medical professionals by providing initial segmentations that must be reviewed, confirmed, or modified using external DICOM-RT compatible platforms. It does not alter original MRI images, is not designed for tumor detection or diagnosis, and requires the user to have prior knowledge of the tumor type; regression testing confirmed VBrain meets its performance requirements and specifications.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What are the specific performance metrics (e.g., Dice similarity coefficient, Hausdorff distance) of the VBrain deep learning algorithms for contouring different tumor types (metastases, meningiomas, acoustic neuromas) and organs at risk compared to manual expert contours?; How does the VBrain system handle variability in MRI acquisition parameters (e.g., scanner manufacturer, field strength, sequence parameters) across different institutions, and what is its robustness to such variations?; What was the diversity of the patient dataset used for training and validating the deep learning models, particularly concerning tumor morphology, size, location, and patient demographics?; How does the integration of VBrain's tumor and OAR contouring modules with the image registration feature enhance the overall efficiency and accuracy of the radiation therapy treatment planning workflow?; What are the computational requirements (e.g., processing time, hardware specifications) for VBrain to process a typical brain MRI dataset for both contouring and registration tasks?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, HBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly